110
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract

, , , &
Pages 853-859 | Published online: 09 Jul 2013

References

  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet200536594721687171715894097
  • French Adjuvant Study GroupBenefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trialJ Clin Oncol200119360261111157009
  • RiccardiABrugnatelliSGiordanoMMyeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast CancerTumori19988455405469862513
  • BaltaliEGunelNOnatDANeoadjuvant chemotherapy in locally advanced breast cancer: a preliminary report. Turkish Oncology Study GroupTumori199985648348710774570
  • KornblithABLanLArcherLQuality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907J Clin Oncol20112981022102821300923
  • MartinMLluchASeguiMAToxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimenAnn Oncol20061781205121216766587
  • ApetohLGhiringhelliFTesniereAToll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNat Med20071391050105917704786
  • MozaffariFLindemalmCChoudhuryANK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapyBr J Cancer200797110511117551492
  • KawanishiTIkeda-DantsujiYNagayamaAEffects of two basidiomycete species on interleukin 1 and interleukin 2 production by macrophage and T cell linesImmunobiology2010215751652019913939
  • SuganoNChojiYHibinoYAnticarcinogenic action of an alcohol-insoluble fraction (LAP1) from culture medium of Lentinus edodes myceliaCancer Lett1985271164039972
  • SuganoNHibinoYChojiYMaedaHAnticarcinogenic actions of water-soluble and alcohol-insoluble fractions from culture medium of Lentinus edodes myceliaCancer Lett19821721091146891904
  • LiuMLiJKongFLinJGaoYInduction of immunomodulating cytokines by a new polysaccharide-peptide complex from culture mycelia of Lentinus edodesImmunopharmacology19984031871989858062
  • TanakaKMatsuiYIshikawaSKawanishiTHaradaMOral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecumOncol Rep201227232533222086364
  • TanakaKIshikawaSMatsuiYTamesadaMHarashimaNHaradaMOral ingestion of Lentinula edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell-mediated immunosuppressionCancer Sci2011102351652121261790
  • YamaguchiYMiyaharaEHiharaJEfficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: a pilot studyAm J Chin Med201139345145921598414
  • OkunoKUnoKEfficacy of orally administered Lentinula edodes mycelia extract for advanced gastrointestinal cancer patients undergoing cancer chemotherapy: a pilot studyAsian Pac J Cancer Prev20111271671167422126542
  • National Cancer Institute, U.S.:Common Terminology Criteria for Adverse Events V2.0 [Publish Date April 30, 1999]. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf
  • KuriharaMShimizuHTsuboiKDevelopment of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapyPsychooncology19998435536310474853
  • LindqvistCAChristianssonLHSimonssonBEnbladGOlsson-StrömbergULoskogAST regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignanciesImmunology2010131337137620518821
  • MocchegianiECiavattiniASantarelliLRole of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinomaBr J Cancer19997922442509888464
  • ArchiliCLissoniPCattaneoGLack of changes in soluble interleukin-2 receptor serum levels during chemotherapy-induced lymphocyte damageInt J Biol Markers19905143452172411
  • MurtaEFde AndradeJMFalcãoR PBighettiSLymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapyTumori200086540340711130570
  • ToyamaYYoshidaSSaitoRSuccessful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients’ quality of lifeWorld J Surg Oncol201311323302293
  • LinKYShunSCLaiYHLiangJTTsauoJYComparison of the effects of a supervised exercise program and usual care in patients with colorectal cancer undergoing chemotherapyCancer Nurs [Epub January 25, 2013]
  • StigtJAUilSMvan RiesenSJA randomized controlled trial of postthoracotomy pulmonary rehabilitation in patients with resectable lung cancerJ Thorac Oncol20138221422123238118